Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumab.
Saved in:
| Title: | Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumab. |
|---|---|
| Authors: | Gogas H; National and Kapodistrian University of Athens, Athens, Greece. helgogas@gmail.com., Ravimohan S; Bristol Myers Squibb, Princeton, NJ, USA., Datta A; Bristol Myers Squibb, Princeton, NJ, USA., Chhibber A; Bristol Myers Squibb, Princeton, NJ, USA., Couselo EM; Vall d'Hebron Barcelona Hospital and Vall d'Hebron Instituto de Oncología (VHIO), Barcelona, Spain., Diab A; MD Anderson Cancer Center, Houston, TX, USA., Pereira C; Fundação Pio XII - Hospital de Câncer de Barretos, São Paulo, Brazil., Quéreux G; Unité Cancéro-Dermatologie, Nantes, France., Sandhu S; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Curti B; Eerle A. Chiles Research Institute, Providence Cancer Institute of Oregon, Portland, OR, USA., Khushalani NI; Moffitt Cancer Center, Tampa, FL, USA., Taylor MH; Eerle A. Chiles Research Institute, Providence Cancer Institute of Oregon, Portland, OR, USA., Daniels GA; Moores UCSD Cancer Center, La Jolla, CA, USA., Spreafico A; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Meniawy T; Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Australia., Van Den Eertwegh AJM; Department of Medical Oncology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands., Sun Y; Bristol Myers Squibb, Princeton, NJ, USA., Arriaga Y; Bristol Myers Squibb, Princeton, NJ, USA., Zhou M; Bristol Myers Squibb, Princeton, NJ, USA., Long GV; The Melanoma Institute Australia, The University of Sydney and Royal North Shore and Mater Hospitals, Sydney, NSW, Australia., Lebbé C; Université Paris Cité, Dermato-Oncology and CIC AP-HP Hôpital Saint Louis, Cancer Institute APHP, Nord-Université Paris Cité, Paris, France.; INSERM U976 HIPI, Paris, France. |
| Source: | NPJ precision oncology [NPJ Precis Oncol] 2024 Jul 19; Vol. 8 (1), pp. 150. Date of Electronic Publication: 2024 Jul 19. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2397-768X |
|---|---|
| DOI: | 10.1038/s41698-024-00641-7 |
